Lauren Newnam, DPM
Foot & Ankle Surgery · Laurel, MDNPI 1629186218
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (40.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 38 manufacturers reported payments, led by Arthrex at 41.0% of the total. Reporting peaked in 2020 at $4,460 and has fallen 69.2% since, to $1,372 in 2025.
Across 121 payments — averaging $86.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Supreme Orthopedic Systems, LLC$3K
- Integra Lifesciences Corporation$918
- Organogenesis Inc.$293
- Next Science LLC$169
- Treace Medical Concepts, Inc.$125
- plus $2K from 32 others
What the payments were for
- Travel & lodging$2,07420%
- Food & beverage$3,24331%
- Education$4,25241%
- Other$8959%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $4,291 |
| Supreme Orthopedic Systems, LLC | 26 | $3,128 |
| Integra Lifesciences Corporation | 3 | $918 |
| Organogenesis Inc. | 6 | $293 |
| Next Science LLC | 5 | $169 |
| Treace Medical Concepts, Inc. | 1 | $125 |
| Averitas Pharma Inc. | 4 | $118 |
| Reflow Medical Inc | 1 | $118 |
| Abbott | 1 | $110 |
| KCI USA, Inc. | 3 | $107 |
| Amgen | 4 | $94 |
| Bone Support Inc. | 1 | $90 |
| Smith+Nephew | 5 | $88 |
| Solventum Corporation | 4 | $81 |
| Native Surgical, LLC | 2 | $74 |
| Lundbeck LLC | 3 | $65 |
| Biogen | 3 | $63 |
| CSL Behring | 3 | $60 |
| UCB, Inc. | 2 | $57 |
| Reapplix Inc. | 1 | $53 |
| Stryker | 1 | $33 |
| Sanara Medtech Inc. | 2 | $31 |
| Zimmer Biomet | 1 | $28 |
| Vertos Medical, Inc. | 1 | $24 |
| Radius Health, Inc. | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Kerecis Limited | 1 | $20 |
| AstraZeneca | 1 | $20 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Trevena, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Neurelis, Inc. | 1 | $18 |
| Seqirus USA Inc | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $15 |
| Orthofix Medical, Inc. | 1 | $15 |
| Acumed LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTEGRA$649
- MICROMATRIX$245
- Lapiplasty System$125
- DISTAL EXTREMITIES IMPLANTS SOFT TISSUE ANCHORS$124
- Apligraf$115
- ESPRIT$110
How this compares
$10,464 in reported general payments places this provider in the 80th percentile of 182 foot & ankle surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levofloxacin | 15 | $50 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Laurel
- Aree SaedLaurel$5K
- Lew SchonBaltimore$752K
- Stuart MillerBaltimore$583K
- Mark SpierGlen Burnie$400K
- Patrick MaloneyBaltimore$262K
- Jeffrey BrodieTowson$240K
- Gregory GuytonBaltimore$216K
- Hummira AbawiColumbia$123K
- Eric HarmelinAnnapolis$118K
- Donald HarrisonPasadena$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.